CRT 2025

Panel Discussion

Panel Moderator(s)

• 

  Ran Kornowski, MD

  Chairman, Department of Cardiology
  Rabin Medical Center
  Petach-Tikva, Israel

  Disclosure(s): Medtronics-Cathworks: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
• 

  Angela E. McInerney, MD

  Interventional Cardiologist
  University Hospital Galway, Ireland , Clare, Ireland

  Disclosure(s): No financial relationships to disclose
• 

  Augusto Pichard, MD, FACC, MSCAI, FSFC

  Interventional cardiologist
  MEDSTAR Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

• 

  Chirag Bavishi, MD, MPH

  Director, Structural Heart Program
  University of Missouri at Columbia

  Disclosure(s): No financial relationships to disclose
• 

  Philippe Généreux, MD

  Co-Director, Valve & Structural Heart Center
  Morristown Medical Center
  Morristown, New Jersey, United States

  Disclosure information not submitted.
• 

  Richard J. Jabbour, MD

  Interventional Cardiologist
  Southampton General Hospital
  Southampton , England, United Kingdom

  Disclosure(s): medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Giorgio A. Medranda, MD

  Structural Interventional Cardiologist
  NYU Langone Hospital - Long Island
  Glen Cove, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Hany Ragy, MD

  Director of Cath lab
  hayat hospital Cairo
  cairo, Egypt

  Disclosure information not submitted.
• 

  Grant W. Reed, MD, MSc

  Program Director, Interventional Cardiology Fellowship
  Cleveland Clinic
  Cleveland, Ohio, United States

  Disclosure(s): Abbott Laboratories: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• FS

  Francesco Saia, MD

  Disclosure information not submitted.
• 

  Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

  Professor and Clinical Director of Interventional cardiology
  Thoraxcenter
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure(s): Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Jason Wasfy, MD

  Director of Outcomes Research
  Massachusetts General Hospital
  Cambridge, Massachusetts, United States

  Disclosure(s): No financial relationships to disclose